Share this

National Waiting Times Centre Board Information

General
Health board National Waiting Times Centre Board
Legal name National Waiting Times Centre Board
HQ address Golden Jubilee National Hospital, Beardmore Street, Clydebank, Glasgow G81 4HX
Postcode G81 4HX
R&D contact details Dr Catherine Sinclair
Key Information
Annual inpatient visits 17,224
Annual outpatient visits 25,274
Annual prescriptions 41,215
R&D Director Prof Keith Oldroyd
Contact Details
Name Dr Catherine Sinclair
Address Golden Jubilee National Hospital, Beardmore Street, Clydebank
Email catherine.sinclair@gjnh.scot.nhs.uk
Telephone 0141 951 5440
Research Infrastructure
Clinical Research Facility? Yes
Research Pharmacy? Yes
Research Imaging? Yes
Can investigators access resources Board wide? Yes
Board Capability
Phase I No | Paediatrics No
Phase II Yes | Paediatrics No
Phase III Yes | Paediatrics No
Phase IV Yes | Paediatrics No
Device studies Yes | Paediatrics No
Stem cell studies Yes | Paediatrics No
Gene therapy studies Yes | Paediatrics No
Vaccine studies No | Paediatrics No
Observational studies Yes | Paediatrics No
Site Details
Name Address
Golden Jubilee National Hospital Beardmore Street, Clydebank

GJNH R&D facilitates and supports high quality research – i.e. research that conforms to the quality standards required by guidance (the Research Governance Framework for Health and Community Care SGHD 2006) and legislation (the EU Clinical Trials Directive). The Board hosts projects sponsored by device and pharmaceutical companies as well as projects sponsored by Universities and by other NHS Organisation.

We are committed to facilitating rapid set up of projects. The average time taken the review process for all studies approved in the 12/13 financial year was 8 days – the CSO target is 30 days – with 38% sponsored and funded by commercial companies. Currently performance management of projects is done through the R&D Office and the R&D Steering Group and recently a post was introduced with a remit of performance managing recruitment by direct interaction with the research teams.

The GJNH has a Clinical Research Facility which has four consulting rooms, a research support office, a secure file room and a small laboratory. All follow-up visits take place in the CRF. For more information, visit the research section of the BCHS websitehttp://www.beardmorehealthscience.com/research.htm 

Clinical Specialities

As a tertiary referral centre, the GJNH specialises in a number of areas for the population of the West of Scotland and, in the case of the National Services, the whole of Scotland. All clinical specialities are research active hosing commercially sponsored and funded studies and academic studies through links with Universities.

Clinical Specialities are listed below: 

Cardiology services: Including: Diagnosis and treatment of arrhythmias; Procedures involving the coronary arteries, including heart attack; Diagnosis and treatment for various coronary, lung, congenital heart disease and electrophysiological disorders.

Orthopaedic services: Including: Primary Hip Replacement (cemented, cementless, ceramic); Primary Knee Replacement; Unicompartimental Knee Replacement: Revision Hip Replacement; Revision Knee Replacement; Prosthetic Infections; Periprosthetic Fractures around a Hip and Knee Replacement; Knee Arthroscopy; Anterior Cruciate Ligament Reconstruction; Foot Surgery (including hammer toes and bunions) and Hand Surgery (including Carpal Tunnel decompressions, Ganglions, Dupuytren’s Contracture). 

Scottish Adult Congenital Cardiac Service (SACCS): This service cares for patients with moderate to complex congenital heart disorders. The multidisciplinary team provide a full range of support, care and treatment services, including interventional and surgical services, to manage congenital heart disease patients who are 16 years old or over.

Scottish National Advanced Heart Failure Service (SNAHFS): This service is dedicated to managing patients with severe heart failure who may be candidates for heart transplantation and/or ventricular assist devices (artificial hearts). Clinicians provide a national service caring for patients throughout Scotland from the Borders to the Shetland Islands. The following treatment options are available: Defibrillators; Cardiac Resynchronization Devices (pacemakers); Ventricular Assist Devices (VADs); ECMO (a technique that oxygenates blood outside the body); and Heart Transplantation. 

The Scottish Pulmonary Vascular Unit (SPVU): This service provides quality care for all patients with pulmonary hypertension in Scotland as follows: Investigation, treatment and provision of long-term follow-up for patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. 

Support services: The clinical services listed above are supported by services including: anaesthetics, cardiac physiology, perfusion, pharmacy, rehabilitation and radiology - general X-ray, Magnetic Resonance Imaging (MRI) scanning, Computer Tomography (CT) scanning, bone densitometry, ultrasound, DEXA scanning and cardiac catheterisation.  

Back